Resistance studies with daptomycin - Wikidata - awgldk - TriplyDB

Resistance studies with daptomycin

Resistance studies with daptomycin

http://www.wikidata.org/entity/Q33982318

about

Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae Mechanisms of drug resistance: daptomycin resistance Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin Kinetic analysis and modeling of daptomycin batch fermentation by Streptomyces roseosporus.A potential role for daptomycin in enterococcal infections: what is the evidence?Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.Axinellamines as broad-spectrum antibacterial agents: scalable synthesis and biology.Therapies in development for community-acquired pneumonia.Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.Biological properties of novel antistaphylococcal quinoline-indole agents.Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001 In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains.Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens.Novel agents for the treatment of resistant Gram-positive infections.Pharmacological properties of the marine natural product marinopyrrole A against methicillin-resistant Staphylococcus aureus.Novel antibacterial agents for the treatment of serious Gram-positive infections.Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate.Vancomycin resistance: occurrence, mechanisms and strategies to combat it.Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections.Treatment of gram-positive deep sternal wound infections in cardiac surgery--experiences with daptomycin.Daptomycin.Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections.Daptomycin - a novel antibiotic against Gram-positive pathogens.Impact of daptomycin resistance on Staphylococcus aureus virulence.Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.Oritavancin: a new avenue for resistant Gram-positive bacteria.Intrinsic and acquired resistance mechanisms in enterococcus.Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.Update on daptomycin: the first approved lipopeptide antibiotic.Population pharmacokinetics of daptomycin Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.Analysis of daptomycin efficacy and breakpoint standards in a murine model of Enterococcus faecalis and Enterococcus faecium renal infection Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus.Emergence of daptomycin-resistant VRE: experience of a single institution.

P2860

Q24656785-639C2DFD-DCD8-4C42-BFD2-2EA9A28C273C Q26779944-D45E08D2-BED7-412C-BDE9-1FFB813E5C10 Q33233009-E44D2D28-CA8A-46FC-8D2F-F96895C944C5 Q33681139-172EFB8D-F8AA-4FD3-B8ED-D488A9AFDDE9 Q33845776-DD92B857-B7C2-473B-A6CF-A253B69C01FE Q33939055-7EA1A62F-9D14-4352-93D0-C2DC810149EB Q34073487-522E2BFA-C7F8-4C85-BCF5-1E74D55DB993 Q34330270-3DD1D274-9237-45BD-8AFC-ADCE3096A510 Q34489878-08CB1EBD-604D-422C-8D0E-2FD0F94414E1 Q34581508-631456F8-CA8C-42EF-997E-926E7ED07FAD Q34648042-E6505022-77C4-405B-A5D7-3CE89016ED27 Q34680589-164C26FE-7BDA-4AA4-B9E7-B690D1E20C4C Q34821242-CB662F04-3CF5-4403-A3F4-A01794F58651 Q34939045-A6CFEF0D-5040-4039-9129-6A7827048183 Q34973784-D1C0A5E5-3AD1-4036-A1A0-FC311DBBEDB1 Q35023234-4E9A4A39-700F-482B-97AB-AE1E07937AFD Q35026595-8D8437B6-2CC5-4AD3-AFEE-89DB9ECE0188 Q35056042-9B2B3F5D-4FDB-4B85-A860-C5F1C1F274D8 Q35065758-22A5DECA-169C-48AD-8537-D4A5E363BDC3 Q35073345-AD8D8419-95D8-443C-99C5-D058F4D9150C Q35139509-6E2C4227-144C-419C-AE2B-A3FD09F8FE0A Q35143886-9D90BCA5-E1C6-4B15-AEC0-52C7BDD54E82 Q35166213-258B7637-6CD3-4AB4-9848-18C8B966A8BE Q35166807-801D6B8F-58F8-431E-816C-0DDEAD83775D Q35248216-9614A4CE-04DF-478A-8B31-3668AA24C1A4 Q35637066-08CA2383-DC85-4A77-BCE9-CB38893EC2D0 Q35701450-2CD14F44-3A2B-46B4-9A7E-F2687010649B Q35871928-DDB83BB5-0CE3-4E8F-9AB9-0E35915F9985 Q35925535-EDF3BFCC-08AE-4E28-B123-38E4DF149C2C Q36147127-1AC2DE0F-2BF2-46F2-9A17-98C194C4FF35 Q36158472-47D2EF63-3FB5-4B7C-8771-1C42FCD71D60 Q36162339-03D57F08-752C-4C04-A692-3F4DF49C2C6E Q36362547-CC177615-42C6-406D-AF19-AEE09D56FF9C Q36482313-DDD7116B-25EE-46DB-B1E6-079525698C5A Q36521880-E48D872B-C059-4BC3-9A0E-A58CEA1D53C9 Q36670451-49CC9EEE-9070-48BE-B9BE-0E617AE9EBDC Q36777821-F1BA0CC5-1B34-4056-AE72-644E6EBDAAD4 Q36879791-2D48013A-5546-48D2-95E1-E2EFD210ABF8 Q36903680-79C7C8F9-AF70-4AEB-82AE-639F64A06C6C Q36914057-39335973-34AA-4D3F-BEF4-AC5944212E86

P2860

Resistance studies with daptomycin

http://www.wikidata.org/entity/Q33982318

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Resistance studies with daptomycin

@ast

Resistance studies with daptomycin

@en

type

label

Resistance studies with daptomycin

@ast

Resistance studies with daptomycin

@en

prefLabel

Resistance studies with daptomycin

@ast

Resistance studies with daptomycin

@en

P1433

Q33982318-3BCDA6F3-FCCC-4BB0-8EBF-2028BBA8192D

P1476

Q33982318-D891C59F-2D79-4B5B-B783-F3CFED928DE8

P2093

Q33982318-578B354E-195A-48CF-A2E3-4A586FF68BF4

Q33982318-85BBF308-8178-419C-8C6A-69C1DC62D1CB

Q33982318-8955EBA7-7F90-481A-BF00-66FC69D36CC0

Q33982318-CB442EF7-3963-4E1F-91C1-FF62D49F6573

P2860

Q33982318-01015153-9D1D-4F74-BD00-D2233D53823F

Q33982318-0BDE55C1-3EB0-4589-8296-739336CBEC19

Q33982318-156AA466-4871-480E-956E-499FE9E71258

Q33982318-1BC40140-540E-4B1B-8224-9FDB75F0B49F

Q33982318-2248AE6C-E853-4C10-B39D-ADC6ABEBD765

Q33982318-2753DA51-FB56-4E76-8CE5-726EBF878DB6

Q33982318-45A7F6E0-D4CA-43EC-9200-F2660FF2A49B

Q33982318-55E59577-2205-42C7-9632-AE090C752B00

Q33982318-576CBE03-85F3-4302-9F56-130F4F41C248

Q33982318-6B710604-D6E0-40FC-9678-F1E673D63851

P304

Q33982318-2D1A3771-72D1-4C02-A0F6-4D2ED42FAFF0

P31

Q33982318-6FD7483E-15B3-4C26-BF4E-0C229B5CF0AF

P356

Q33982318-40B82232-EE72-4175-A3D2-EE8990E210F8

P407

Q33982318-17381985-64AB-464F-82E0-A96AB59B630E

P433

Q33982318-61BE3370-15B3-4D9D-9616-DCA6B383CA5D

P478

Q33982318-0F87CE01-2915-49A3-A094-FD4BFEE03D36

P577

Q33982318-7AAF3F41-0465-4A1B-BE1F-E0A9304C978F

P698

Q33982318-92256965-B5DE-42AC-915E-5F98EAE11971

P932

Q33982318-CA5DD809-3C0C-4DA1-8D99-A30977AE0D61

P356

AAC.45.6.1799-1802.2001

P1433

Antimicrobial Agents and Chemotherapy

P1476

Resistance studies with daptomycin

@en

P2093

J A Silverman

http://www.w3.org/2001/XMLSchema#string

N Oliver

http://www.w3.org/2001/XMLSchema#string

T Andrew

http://www.w3.org/2001/XMLSchema#string

T Li

http://www.w3.org/2001/XMLSchema#string

P2860

Use of bacteriophage-resistant mutants to study the nature of the bacteriophage receptor site of Staphylococcus aureus.

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.

Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens

Proton motive force during growth of Streptococcus lactis cells.

Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae

Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.

Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.

Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.

In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic

Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus.

P304

1799-1802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.45.6.1799-1802.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11353628

http://www.w3.org/2001/XMLSchema#string

P932

90548

http://www.w3.org/2001/XMLSchema#string